Alpha 2.0
Login Register
» Authors » Dovile Zilenaite-Petrulaitiene

Dovile Zilenaite-Petrulaitiene

Explore the profile of Dovile Zilenaite-Petrulaitiene including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 5
Citations 6
Followers 0
Related Specialties
Oncology
General Medicine
General Surgery
Top 10 Co-Authors
Arvydas Laurinavicius
Allan Rasmusson
Aiste Gulla
Rokas Stulpinas
Kestutis Strupas
Linas Petkevicius
Aida Laurinaviciene
Ruta Barbora Valkiuniene
Agne Grigonyte
Benoit Plancoulaine
Published In
Cancers (Basel)
Curr Oncol
J Surg Res
PLoS One
Virchows Arch
Affiliations
Soon will be listed here.
Recent Articles
1.
Spatial distributions of CD8 and Ki67 cells in the tumor microenvironment independently predict breast cancer-specific survival in patients with ER+HER2- and triple-negative breast carcinoma
Zilenaite-Petrulaitiene D, Rasmusson A, Valkiuniene R, Laurinaviciene A, Petkevicius L, Laurinavicius A
PLoS One . 2024 Nov; 19(11):e0314364. PMID: 39576843
Introduction: Breast cancer (BC) presents diverse malignancies with varying biological and clinical behaviors, driven by an interplay between cancer cells and tumor microenvironment. Deciphering these interactions is crucial for personalized...
2.
Low CD8+ Density Variation and R1 Surgical Margin as Independent Predictors of Early Post-Resection Recurrence in HCC Patients Meeting Milan Criteria
Stulpinas R, Jakiunaite I, Sidabraite A, Rasmusson A, Zilenaite-Petrulaitiene D, Strupas K, et al.
Curr Oncol . 2024 Sep; 31(9):5344-5353. PMID: 39330022
Our study included 41 patients fulfilling the Milan criteria preoperatively and aimed to identify individuals at high risk of post-resection HCC relapse, which occurred in 18 out of 41 patients...
3.
Intratumoral heterogeneity of Ki67 proliferation index outperforms conventional immunohistochemistry prognostic factors in estrogen receptor-positive HER2-negative breast cancer
Zilenaite-Petrulaitiene D, Rasmusson A, Besusparis J, Valkiuniene R, Augulis R, Laurinaviciene A, et al.
Virchows Arch . 2024 Jan; 486(2):287-298. PMID: 38217716
In breast cancer (BC), pathologists visually score ER, PR, HER2, and Ki67 biomarkers to assess tumor properties and predict patient outcomes. This does not systematically account for intratumoral heterogeneity (ITH)...
4.
Overall Survival Prediction by Tumor Microenvironment Lymphocyte Distribution in Hepatocellular Carcinoma After Liver Transplantation
Gulla A, Stulpinas R, Grigonyte A, Zilenaite-Petrulaitiene D, Rasmusson A, Laurinavicius A, et al.
J Surg Res . 2023 Dec; 295:457-467. PMID: 38070260
Introduction: Our previous research demonstrated that CD8+ cell density profiling using a hexagonal grid-based digital image analysis method provides predictors of patient outcomes after liver resection due to hepatocellular carcinoma...
5.
Prognostic Value of CD8+ Lymphocytes in Hepatocellular Carcinoma and Perineoplastic Parenchyma Assessed by Interface Density Profiles in Liver Resection Samples
Stulpinas R, Zilenaite-Petrulaitiene D, Rasmusson A, Gulla A, Grigonyte A, Strupas K, et al.
Cancers (Basel) . 2023 Jan; 15(2). PMID: 36672317
Hepatocellular carcinoma (HCC) often emerges in the setting of long-standing inflammatory liver disease. CD8 lymphocytes are involved in both the antitumoral response and hepatocyte damage in the remaining parenchyma. We...